MEET DR. MARIUS MAXWELL

Neurosurgeon

Dr. Marius Maxwell is an Ivy League trained, veteran neurosurgeon, with more than 20 years of medical training and over 30 years of neurosurgical experience in the USA. He first received his Medical Degree from Cambridge University in 1985. He then further underwent 14 years of neurosurgical research and training at the prestigious Harvard Medical School and Massachusetts General Hospital, completed in 1998.

Concurrent to doing research at Harvard University, he received a rare and prized scholarship to undertake special research at Oxford University. This was the Senior Germaine at Brasenose College. During this time he worked at both Harvard and Oxford Universities and this research culminated in his Phd (DPhil) in molecular cancer biology of brain tumors from Oxford University.

Dr Maxwell has helped thousands of individuals regain their lives since 1998 and has successfully performed in excess of 10,000 surgeries. He is a Diplomate of the National Board of Physicians and Surgeons (NBPAS) and was Board Certified by the American Board of Neurological Surgeons (ABNS) in 2008. He has also been privileged to serve as a sole expert reviewing neurosurgeon to the Board of Medicine for the State of Alaska. He has published numerous works on spine and neurological conditions and procedures.

Dr. Maxwell’s published research:

Publications

Rivkees SA, Chaar MR, Hanley DF, Maxwell M, Reppert SM, Uhl GR. Localization and regulation of vasopressin mRNA in human neurons, Synapse 3, 246-254, 1989.

Maxwell M, Karacostas D, Brzczinski A, Zervas NT, Precocious puberty following head injury; a case report. J Neurosur 73, 123-129, 1990.

Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET and Antoniades HN, Co-expression of planet derived growth factor (PDGF) genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86, 131-140, 1990.

Bravo MA, Avilla RE, Maxwell M and Antoniades HN. Platelet-derived growth factor in interstitial lung disease. J Clin Invest 86, 1055-1064, 1990.

Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hadley-Whyte ET and Antoniades HN. The expression of angiogenic growth factor genes may determine the malignant progression of human astrocytomas. Cancer Res 51, 1345-1351, 1991.

Maxwell M, Galanopoulos T, Neville-Golden j and Antoniades HN. Effect of the expression of transforming growth factor-82 in primary human glioblastomas on immunosuppression and loss of immune surveillance, J Neurosurg 76, 799-804, 1992.

Antoniades HN, Galanopoulos T, Neville-Golden J. and Maxwell M. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J. Cancer 50, 215-222, 1992.

Maxwell M, Galanopoulos T, Neville-Golden J, and Antoniades HN. Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78, 456-462, 1993.

Hughes-Davies L, Harrison L, Galanopoulos T, Maxwell M, Antoniades HN and Demple B. Expression of the human apurinic endonuclease (APE) gene in normal and malignant tissues. Int J. Oncol 6, 749-752, 1995.

Maxwell M, Galanopoulos T and Antoniades HN. The expression of the ros1 Protooncogene in primary human glioblastomas may lead to malignant progression. Int J. Oncol. 8, 713-718, 1996.

Maxwell M, Galanopoulos T and Antoniades HN. Cell-cycle regulator cyclin DI mRNA and protein over expression occurs in primary malignant gliomas. Int J Oncol., 9, 493-497, 1996.

Calias P. Galanopoulos T, Maxwell M, Khyat A. Graves D, d’Alarcao M and Antoniades HN. Synthesis of Inositol 2-Phosphate-Quercetin Conjugates. Carbohydrates Res 292, 83-90, 1996.

Maxwell M, Galanopoulos T and Antoniades HN. Co-expression of EGFR and TGFa occurs in primary meningiomas. Int J Oncol. 9, 917-922, 1996.

Maxwell M, Galanopoulos T and Antoniades HN. Expression of cyclin D1 tumorigensis. Int  J Oncol. 9, 1213-1217, 1996.

Maxwell M, Shih SD, Galanopoulos T, Hedley-Whyte T and Cosgrove CR. Familial meningioma; a case report with immuncytochemical analysis of N F 2 protein, merlin, expression. J Neurosurg 88, 562-569, 1998.

Maxwell M, Galanopoulos T, Neville-Golden J, Hedley-Whyte ET and Antoniades HN. Cellular localization of PDGF mRNAs in developing human forebrain. Neuropathol Appl Neurobiol. 24, 337-345, 1998

Maxwell M, Borges LF, and Zervas NT. Renal cell carcinoma: a rare source of cauda equina metastasis. J Neurosurgery: Spine 90, 129-132, 1999.

Zhou X, Marsh DJ, Morrison CD, Chaudhury AR, Maxwell M, Reifenberger G and Eng C. Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults. Am J Hum Genet. 73, 1191-1198, 2003.

Dr. Maxwell is also frequently cited on modern scientific and ethical issues. He is a key contributor to VERO (Voice of Ethical Research at Oxford) and his article “Experimental Theatre” was published in The Guardian in 2007. A selection of Dr. Maxwell’s contributing articles are available below.

The Guardian: “Experimental Theatre”

Open Letter: “Lies, Damned Lies and Monkey Science”

Animal Aid UK: “Oxford Vivisectionists are Swimming Against the Tide”

Leading Neuroscientist Speaks Out Against Animal Testing: Statement by VERO